Speaker illustration

Assistant Professor Camilla Gustafsen

Aarhus University Hospital, Aarhus (Denmark)

SorLA is a novel high affinity PCSK9 receptor that inhibits its inactivation by furin

Event: ESC Congress 2016

Topic: Metabolism and metabolic syndromes

Session: Metabolism and hypertrophy


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb